浅谈同步化疗治疗食道癌的临床疗效及毒副作用

目的:探讨同步化疗治疗食道癌的临床疗效及毒副作用。方法:回顾性分析2012年2月至2013年3月在我院进行治疗的64例食道癌晚期患者的临床资料。结果:治疗后,治疗组总有效率为78.13%,显著高于对照组的53.13%,二者具有显著性差异(P<0.05);两组毒副反应发生率相比,无显著性差异(P>0.05)。结论:同步化疗治疗食道癌的临床疗效显著,毒副作用小,值得临床推广。

Objective: To investigate clinical efficacy and side effects of concurrent chemotherapy treatment for esophageal cancer. Methods: Clinical data of 64 patients with esophageal cancer in our hospital from February 2012 to March 2013 were reviewed. Results: After treatment, the total effective rate of treatment group(78.13%) was significantly higher than that of control group(53.13%)(P <0.05); The incidence of adverse reactions between two groups has no significant difference(P > 0.05).Conclusion: Concurrent chemotherapy esophageal cancer have significant clinical efficacy, toxic side effects.